Alfonso Quintás-Cardama

Overview

Alfonso Quintás-Cardama received $2M in total compensation, including $144K in salary, at Foghorn Therapeutics in 2023.

Source: SEC filing on May 3, 2024.

Related executives

We found five more executives who work or worked at Foghorn Therapeutics.

Adrian Gottschalk

Foghorn Therapeutics

Chief Executive Officer

Steven Bellon

Foghorn Therapeutics

Chief Scientific Officer

Allan Reine

Foghorn Therapeutics

Chief Financial Officer

Carl Decicco

Foghorn Therapeutics

Chief Scientific Officer

Samuel Agresta

Foghorn Therapeutics

Chief Medical Officer

News

You may also like